How A Drugmaker Gamed The System To Keep Generic Competition Away
(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read More(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read More(By Julie Spitzer for Becker’s Hospital Review ) Despite a HIPAA-granted right to their own medical records, patients still struggle
Read MoreThe United States Senate Committee on Health, Education, Labor and Pensions (HELP) is calling into question the intent of 340B
Read MoreThe Internal Revenue Service (IRS) announced cost-of-living adjustments for health savings accounts (HSAs) and high-deductible health plans (HDHPs) for 2019.
Read More(By Chad Terhune for California Healthline produced by Kaiser Health News) Cooking dinner one night in March, Mark Frizzell sliced
Read MoreAccording to a new report by the Brookings Institute, the Medicare Advantage (MA) bidding process requires more competition to increase
Read MoreOn Friday, President Trump introduced a blueprint for reducing drug prices called ‘American Patients First”. The 50-point plan addresses four
Read More(By Liz Szabo for Kaiser Health News) Sherry Young just wanted to be able to walk without pain. About three
Read MoreA new study found that antibiotics are linked with an increased risk of developing kidney stones, with the greatest risk
Read More(By Kelly Gooch for Becker’s Hospital Review ) A new Kaiser Family Foundation study provides insights into the growth of
Read More